Vir Biotechnology EVP, CFO Aziz Sawaf files initial beneficial ownership statement
VIR•Vir Biotechnology EVP and Chief Financial Officer Aziz Sawaf filed an initial Form 3 on Oct. 6, 2026.
1. Initial filing
Aziz Sawaf, Vir Biotechnology’s executive vice president and chief financial officer, filed an initial Form 3 on Oct. 6, 2026.
